ANTIESTROGENS IN TREATMENT OF BREAST-CANCER - VALUE OF NAFOXIDINE IN 52 ADVANCED CASES

被引：59

作者：

BLOOM, HJG

BOESEN, E

机构：

[1] ROY MARSDEN HOSP,LONDON SW3,ENGLAND

[2] CHESTER BEATTY RES INST,INST CANC RES,LONDON SW3,ENGLAND

来源：

BRITISH MEDICAL JOURNAL | 1974年 / 2卷 / 5909期

关键词：

D O I：

10.1136/bmj.2.5909.7

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：7 / 10

页数：4

共 25 条

[1]

BLOOM HJG, 1967, CANCER-AM CANCER SOC, V20, P2118, DOI 10.1002/1097-0142(196712)20:12<2118::AID-CNCR2820201209>3.0.CO

[2]

2-U

[3]

BRAUNSBERG H, 1973, LANCET, V1, P163

[4]

COBB L, 1972, PERSONAL COMMUNICATI

[5] NEW ANTI-OESTROGENIC AGENT IN LATE BREAST CANCER - EARLY CLINICAL APPRAISAL OF ICI46474 [J].

COLE, MP ;

JONES, CTA ;

TODD, IDH .

BRITISH JOURNAL OF CANCER, 1971, 25 (02) :270-&

[6]

Dao, 1967, ENDOGENOUS FACTORS I

[7] ESTROGEN RECEPTOR IN HUMAN BREAST-CANCER TISSUE AND RESPONSE TO ENDOCRINE THERAPY [J].

ENGELSMAN, E ;

PERSIJN, JP ;

KORSTEN, CB ;

CLETON, FJ .

BMJ-BRITISH MEDICAL JOURNAL, 1973, 2 (5869) :750-752

[8] ESTRADIOL RECEPTORS IN CARCINOMA AND BENIGN DISEASE OF BREAST - IN-VITRO ASSAY [J].

FEHERTY, P ;

FARRERBR.G ;

KELLIE, AE .

BRITISH JOURNAL OF CANCER, 1971, 25 (04) :697-&

[9]

FOLCA PJ, 1961, LANCET, V2, P796

[10] ESTROGEN RECEPTORS IN HUMAN BREAST-CANCER .2. IN-VITRO BINDING OF ESTRADIOL BY BENIGN AND MALIGNANT TUMORS [J].

HAHNEL, R ;

TWADDLE, E ;

VIVIAN, AB .

STEROIDS, 1971, 18 (06) :681-&

← 1 2 3 →